ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,477 Cr | ₹1,407 Cr | ₹1,343 Cr | ₹1,206 Cr | ₹1,203 Cr |
What is the latest Total Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,477 Cr |
| Mar2025 | ₹1,407 Cr |
| Mar2024 | ₹1,343 Cr |
| Mar2023 | ₹1,206 Cr |
| Mar2022 | ₹1,203 Cr |
How is Total Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,477 Cr | 4.93 | |
| Mar2025 | ₹1,407 Cr | 4.80 | |
| Mar2024 | ₹1,343 Cr | 11.33 | |
| Mar2023 | ₹1,206 Cr | 0.24 | |
| Mar2022 | ₹1,203 Cr | - | |
Compare Total Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹54,782.5 Cr | 0.6% | -0.3% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 0.6% |
-0.3% |
-12.7% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses